Dr. Juan Alderuccio (IMAGE)

University of Miami Miller School of Medicine

Dr. Juan Alderuccio

Caption

Lead researcher Juan Alderuccio, M.D., a hematologist and lymphoma specialist at Sylvester Comprehensive Cancer Center, presented this research Dec. 8, 2025, at the American Society of Hematology meeting in Orlando. The study’s findings could help standardize treatment for T-cell/histocyte-rich large B-cell lymphoma (THRLBCL) — a crucial step toward ensuring patients receive the most effective, least toxic care. 

Credit

Sylvester Comprehensive Cancer Center

Usage Restrictions

Use with attribution

License

Original content

Disclaimer: AAAS and EurekAlert! are not responsible for the accuracy of news releases posted to EurekAlert! by contributing institutions or for the use of any information through the EurekAlert system.